rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Thomas J. Schall

Director

Company insider

Files Form 4 as: Director, Immuneering; President and CEO, ChemoCentryx.

Every Form 4 they filed

In numbers

Trades disclosed
290
Buys
4
Sells
77
Bought
$334K
Sold
$57.7M
Companies
2
Companies where not an officer
1
First trade
27 Feb 2012
Last trade
11 Jun 2026
Last filed
11 Jun 2026

Companies traded

Where they are an officer
ChemoCentryxDirector, Officer · last 20 Oct 20220 buys · 77 sells
Everywhere else they filed: board seats, 10% stakes, other companies
IMRX ImmuneeringDirector · Biotechnology · last 11 Jun 20264 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
02Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Jun 2026filed 11 Jun 2026IMRX Immuneeringoption or derivative · BiotechnologySEC FORM 4 Code A—33,350 at $0.00filing
11 Jun 2026filed 11 Jun 2026IMRX Immuneeringoption or derivative · BiotechnologySEC FORM 4 Code A—33,350 at $0.00filing
15 Jan 2026filed 20 Jan 2026IMRX ImmuneeringBiotechnologySEC FORM 4 Bought$101K21,645 at $4.67filing
15 Jan 2026filed 20 Jan 2026IMRX ImmuneeringBiotechnologySEC FORM 4 Bought$101K21,645 at $4.67filing
27 Jun 2025filed 30 Jun 2025IMRX ImmuneeringBiotechnologySEC FORM 4 Bought$35K9,500 at $3.66filing
17 Jun 2025filed 18 Jun 2025IMRX ImmuneeringBiotechnologySEC FORM 4 Bought$89K40,485 at $2.21filing
13 Jun 2025filed 16 Jun 2025IMRX Immuneeringoption or derivative · BiotechnologySEC FORM 4 Code A—33,350 at $0.00filing
12 Jun 2024filed 13 Jun 2024IMRX Immuneeringoption or derivative · BiotechnologySEC FORM 4 Code A—8,588 at $0.00filing
22 Mar 2024filed 25 Mar 2024IMRX ImmuneeringBiotechnologySEC FORM 4 Bought$7,3952,900 at $2.55filing
11 Mar 2024filed 12 Mar 2024IMRX Immuneeringoption or derivative · BiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
20 Oct 2022filed 24 Oct 2022ChemoCentryxoption or derivativeSEC FORM 4 Code D—4,192filing
20 Oct 2022filed 24 Oct 2022ChemoCentryxoption or derivativeSEC FORM 4 Code D—188,408filing
20 Oct 2022filed 24 Oct 2022ChemoCentryxoption or derivativeSEC FORM 4 Code D—2,502filing
20 Oct 2022filed 24 Oct 2022ChemoCentryxoption or derivativeSEC FORM 4 Code D—68,998filing
20 Oct 2022filed 24 Oct 2022ChemoCentryxoption or derivativeSEC FORM 4 Code D—7,912filing
20 Oct 2022filed 24 Oct 2022ChemoCentryxoption or derivativeSEC FORM 4 Code D—222,088filing
20 Oct 2022filed 24 Oct 2022ChemoCentryxoption or derivativeSEC FORM 4 Code D—11,693filing
20 Oct 2022filed 24 Oct 2022ChemoCentryxoption or derivativeSEC FORM 4 Code D—278,307filing
20 Oct 2022filed 24 Oct 2022ChemoCentryxoption or derivativeSEC FORM 4 Code D—262,431filing
20 Oct 2022filed 24 Oct 2022ChemoCentryxoption or derivativeSEC FORM 4 Code D—17,569filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care4
Not placed77

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.